NCT07170293 2025-09-12Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid TumorsTianjin Medical University Second HospitalPhase 2 Recruiting15 enrolled
NCT05228106 2024-02-0768Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic StudyCentre de recherche du Centre hospitalier universitaire de SherbrookeRecruiting1,000 enrolled